23. The Integration of Safety, Health, and Environmental Considerations into Process Development

  1. Prof. Dr. Takayuki Shioiri4,
  2. Dr. Kunisuke Izawa5 and
  3. Dr. Toshiro Konoike6
  1. Wesley White1,
  2. Vyv Coombe2 and
  3. Jonathan Moseley3

Published Online: 5 OCT 2010

DOI: 10.1002/9783527633678.ch23

Pharmaceutical Process Chemistry

Pharmaceutical Process Chemistry

How to Cite

White, W., Coombe, V. and Moseley, J. (2010) The Integration of Safety, Health, and Environmental Considerations into Process Development, in Pharmaceutical Process Chemistry (eds T. Shioiri, K. Izawa and T. Konoike), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527633678.ch23

Editor Information

  1. 4

    1-18-12 Minamigaoka, Nisshin, Aichi 470-0114, Japan

  2. 5

    Intermediate Chemicals Dept., Ajinomoto Co., Inc., 1-15-1 Kyobashi, Chuo-ku, Tokyo 104-8315, Japan

  3. 6

    CMC Development Laboratories, Shionogi & Co., Ltd., 1-3 Kuise Terajima 2-chome, Amagasaki, Hyogo 660-0813, Japan

Author Information

  1. 1

    AstraZeneca, Milford 2-06, Macclesfield Works, Silk Road Business Park, Charter Way, Macclesfield, Cheshire SK10 2NA, United Kingdom

  2. 2

    AstraZeneca, Brixham Environmental Laboratory, Freshwater Quarry, Brixham, Devon TQ5 8BA, United Kingdom

  3. 3

    AstraZeneca, Avlon Works, Bristol BS10 7ZE, United Kingdom

Publication History

  1. Published Online: 5 OCT 2010
  2. Published Print: 27 OCT 2010

ISBN Information

Print ISBN: 9783527326501

Online ISBN: 9783527633678

SEARCH

Keywords:

  • SHE triggers;
  • process safety;
  • Health;
  • Environmental Assessment;
  • Risk Assessment

Summary

This chapter contains sections titled:

  • Introduction

  • Process Safety

  • Health

  • Environment

  • The Use of Risk Assessment

  • Conclusion

  • Acknowledgments

  • References